176 related articles for article (PubMed ID: 34773357)
1. The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017.
Akter N; Kulinskaya E; Steel N; Bakbergenuly I
BJOG; 2022 May; 129(6):994-1003. PubMed ID: 34773357
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
6. Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer.
McVicker L; Labeit AM; Coupland CAC; Hicks B; Hughes C; McMenamin Ú; McIntosh SA; Murchie P; Cardwell CR
JAMA Oncol; 2024 Jan; 10(1):103-108. PubMed ID: 37917089
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
[TBL] [Abstract][Full Text] [Related]
8. Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study.
Jang JH; Arora N; Kwon JS; Hanley GE
J Obstet Gynaecol Can; 2020 Dec; 42(12):1511-1517. PubMed ID: 32723606
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and asthma onset in menopausal women: National cohort study.
Shah SA; Tibble H; Pillinger R; McLean S; Ryan D; Critchley H; Price D; Hawrylowicz CM; Simpson CR; Soyiri IN; Appiagyei F; Sheikh A; Nwaru BI
J Allergy Clin Immunol; 2021 May; 147(5):1662-1670. PubMed ID: 33279576
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer and hormone replacement therapy in the Million Women Study.
Beral V; ; Bull D; Green J; Reeves G
Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855
[TBL] [Abstract][Full Text] [Related]
12. Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis.
Burkard T; Rauch M; Spoendlin J; Prieto-Alhambra D; Jick SS; Meier CR
Maturitas; 2020 Feb; 132():17-23. PubMed ID: 31883658
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
14. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.
Hunt K; Vessey M; McPherson K
Br J Obstet Gynaecol; 1990 Dec; 97(12):1080-6. PubMed ID: 2126197
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
McMenamin Ú; Hicks B; Hughes C; Murchie P; Hippisley-Cox J; Ranger T; Coupland C; Cardwell C
BMC Cancer; 2021 Mar; 21(1):313. PubMed ID: 33761919
[TBL] [Abstract][Full Text] [Related]
18. Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database.
Bromley SE; de Vries CS; Farmer RD
BJOG; 2004 Apr; 111(4):369-76. PubMed ID: 15008775
[TBL] [Abstract][Full Text] [Related]
19. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
[TBL] [Abstract][Full Text] [Related]
20. Hormone Replacement Therapy and Risk of Severe Asthma Exacerbation in Perimenopausal and Postmenopausal Women: 17-Year National Cohort Study.
Nwaru BI; Shah SA; Tibble H; Pillinger R; McLean S; Ryan D; Critchley H; Hawrylowicz CM; Simpson CR; Soyiri IN; Appiagyei F; Price D; Sheikh A
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2751-2760.e1. PubMed ID: 33705997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
